Historical Stock Returns for Gland Pharma ScanXNewsGland Pharma Projects Growth Through Capacity Expansion and Product Diversification Gland Pharma Reports 12% Increase in Q2 Net Profit, Revenue Grows 5.8% 2 min read Updated on 03 Nov 2025, 04:46 PM Reviewed by Riya DScanX News Team AI Summary Gland Pharma Limited announced its Q2 FY2024 results, showing significant growth
Empagliflozin/Finerenone combo : A fixed-dose combination approved for patients with type 2 diabetes and advanced chronic kidney disease
Smaller compensation: Payouts are typically divided equally among plaintiffs, potentially resulting in smaller individual amounts
At En Vogue IV Therapy & Wellness, we offer Semaglutide GLP-1 injections to help patients achieve sustainable weight loss results
But in the background, work on the role of glucose in the brain, and on insulins role in regulating it, has piled up, along with other possible mechanisms